Assura PLC Notice of Results (1656Z)

TIDMAGR

RNS Number : 1656Z

Assura PLC

12 May 2023

12 May 2023

Assura plc

Notice of Year End Results

Assura plc ("the Company"), the UK's leading primary care property investor and developer will announce results for the year ended 31 March 2023 on Tuesday 23 May 2023.

A presentation for analysts and investors, immediately followed by a Q&A with members of the senior management team, can be viewed at 9.00 am BST at the following link:

https://brrmedia.news/AGR_FY

- Ends -

For more information, please contact:

 
  Assura plc                          Tel: [phone] 
   David Purcell, Investor Relations   E mail: [e-mail] 
   Director 
  Finsbury Glover Hering              Tel: [phone] 
   Gordon Simpson                      Email: [e-mail] 
   James Thompson 
 

Notes to Editors

Assura plc is a national healthcare premises specialist and UK REIT based in Warrington, UK - caring for more than 600 primary healthcare buildings, from which almost seven million patients are served.

A constituent of the FTSE 250 and the EPRA* indices, as at 31 December 2022, Assura's portfolio was valued at GBP2.7 billion.

At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026.

Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.

Further information is available at www.assuraplc.com

* EPRA is a registered trademark of the European Public Real Estate Association

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NORZZGMKVMRGFZM

(END) Dow Jones Newswires

May 12, 2023 02:00 ET (06:00 GMT)